FDA Approves Edwards' Sapien 3 TAVR System

FDA Approves Edwards' Sapien 3 TAVR System-graysheet: The third-generation transcatheter aortic valve has been available in Europe for over a year, will have a long head-start on rival Medtronic's next generation TAVR, Evolut R, in the U.S. market.